AT1RAngII Type 1 Receptor (gene)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Previous studies showed that different polymorphisms in AT1R and AT2R gens have various effects on hypertension (15, 16).
It must be noted that the determination of distinct ARC and angiotensin levels cannot enable a complete understanding of resulting pathophysiologic RAS effects, particularly those mediated by AngII, which still depend on angiotensin receptor regulation and integrity of AT1R blockade if present.
Complementary DNA was synthesized from total RNA using the Power cDNA Synthesis kit, and polymerase chain reactions for human PPAR[delta], human AT1R, human TNF[alpha], human [beta]-actin, mouse PPAR[delta], mouse PPARy, mouse fatty acid synthase (FAS), mouse [beta]-actin, bovine PPAR[delta], bovine monocyte chemoattractant protein-1 (MCP-1), and bovine glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were performed using a PCR Premix kit.
In clinical settings, we report an important observation that inhibition of Ang II using telmisartan (an AT1R blocker) reversed the negative effect on EPC bioactivities caused by Ang II, by restoring complex formation of AT1R and ADRB2.
Cicala et al., "Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism," Journal of the American Society of Hypertension, vol.
The structure of angiotensin II type 1 receptor, AT1R encoded PDB ID: 4YAY [24], was downloaded from the protein data bank (PDB) before performing the docking studies, and this 3D structure was prepared by removing the water molecules and adding polar hydrogens using Autodock Tools 1.5.6 [25].
Hyperthyroidism induces cardiac hypertrophy by promoting the expression of angiotensin type 1 receptor (AT1R).
The first series (n = 4) evaluated the effect on miR-19a and miR-20a and TF expression of HG versus CG and the second one (n = 9) evaluated the effect of LPS (100 ng/mL) stimulation on PBMCs incubated in CG or HG conditions, either per se or in presence of Olmesartan (OLM) ([10.sup.-6] M), an ATII type 1 receptor (AT1R) antagonist [7].
Abbreviations Abs: Antibodies AT1R: Angiotensin receptor 1 DSA: Donor-specific antibodies EBV: Epstein-Barr virus FDA: Federal Drug Administration (US) HC: Heavy chain HIV: Human immunodeficiency virus HLA: Human leukocyte antigens IL-6R: Interleukin-6 receptor IVIg: Intravenous immunoglobulin mAb: Monoclonal antibody MFI: Mean fluorescent intensity MHC: Major histocompatibility complex NDSA: Nondonor-specific antibodies PBMC: Peripheral blood mononuclear cells PHA: Phytohemagglutinin PRA: Panel reactive antibodies TFL: Terasaki Foundation Laboratory TRALI: Transfusion-related acute lung injury Tregs: T-regulatory cells.
Blockade of angiotensin II type I receptor (AT1R) or angiotensin converting enzyme inhibitor has shown promising improvement in chronic hyperglycemia-induced renal injury.
Metabolites of the rennin--angiotensin system, especially angiotensin II, activates AT1R receptor in retina and leads to the formation of reactive oxygen species.
p100 increases AT1R expression through interaction with AT1R 3'-UTR.